PDB Short entry for 1ZAP HEADER ASPARTIC PROTEASE 16-JAN-96 1ZAP TITLE SECRETED ASPARTIC PROTEASE FROM C. ALBICANS COMPND MOL_ID: 1; COMPND 2 MOLECULE: SECRETED ASPARTIC PROTEINASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: SAP, CANDIDA ALBICANS PROTEASE, CAP; COMPND 5 EC: 3.4.23.24 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CANDIDA ALBICANS; SOURCE 3 ORGANISM_TAXID: 5476; SOURCE 4 STRAIN: VAL-1; SOURCE 5 VARIANT: PATHOGENIC CLINICAL ISOLATE FROM SKIN; SOURCE 6 TISSUE: SKIN; SOURCE 7 OTHER_DETAILS: CLOSEST ATTC HOMOLOG IS SAP2 ISOLATED FROM C. SOURCE 8 ALBICANS KEYWDS ASPARTIC PROTEASE, SECRETED, CANDIDA ALBICANS EXPDTA X-RAY DIFFRACTION AUTHOR C.ABAD-ZAPATERO,S.W.MUCHMORE REVDAT 4 18-JAN-12 1ZAP 1 REMARK REVDAT 3 13-JUL-11 1ZAP 1 VERSN REVDAT 2 24-FEB-09 1ZAP 1 VERSN REVDAT 1 21-APR-97 1ZAP 0 JRNL AUTH C.ABAD-ZAPATERO,R.GOLDMAN,S.W.MUCHMORE,C.HUTCHINS,K.STEWART, JRNL AUTH 2 J.NAVAZA,C.D.PAYNE,T.L.RAY JRNL TITL STRUCTURE OF A SECRETED ASPARTIC PROTEASE FROM C. ALBICANS JRNL TITL 2 COMPLEXED WITH A POTENT INHIBITOR: IMPLICATIONS FOR THE JRNL TITL 3 DESIGN OF ANTIFUNGAL AGENTS. JRNL REF PROTEIN SCI. V. 5 640 1996 JRNL REFN ISSN 0961-8368 JRNL PMID 8845753 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH S.M.CUTFIELD,E.J.DODSON,B.F.ANDERSON,P.C.MOODY,C.J.MARSHALL, REMARK 1 AUTH 2 P.A.SULLIVAN,J.F.CUTFIELD REMARK 1 TITL THE CRYSTAL STRUCTURE OF A MAJOR SECRETED ASPARTIC REMARK 1 TITL 2 PROTEINASE FROM CANDIDA ALBICANS IN COMPLEXES WITH TWO REMARK 1 TITL 3 INHIBITORS REMARK 1 REF STRUCTURE V. 3 1261 1995 REMARK 1 REFN ISSN 0969-2126 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 8.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 10193 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.145 REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2535 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 54 REMARK 3 SOLVENT ATOMS : 189 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.66 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1ZAP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : JUN-93 REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU REMARK 200 INTENSITY-INTEGRATION SOFTWARE : R-AXIS, DENZO REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 10193 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 8.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.500 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 89.0 REMARK 200 DATA REDUNDANCY : 3.000 REMARK 200 R MERGE (I) : 0.09900 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.96 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.12 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 31.80000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 24.64000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 49.13000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 24.64000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 31.80000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 49.13000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 THIS ENZYME IS A VERY CLOSE HOMOLOGUE OF THE SECRETED REMARK 400 ASPARTIC PROTEASE FROM C. ALBICANS (ATCC 10261) REFERRED TO REMARK 400 AS SAP2. THE DEPOSITORS REFER TO IT AS SAP2X. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PHE A 251 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 206 CB CG CD CE NZ REMARK 470 ASN A 257 CB CG OD1 ND2 REMARK 470 ALA A 280 CB REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O LEU A 159 H ASN A 160 1.03 REMARK 500 C LEU A 159 H ASN A 160 1.24 REMARK 500 HH12 ARG A 312 H1 HOH A 665 1.31 REMARK 500 HZ2 LYS A 271 H1 HOH A 655 1.34 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 617 O HOH A 764 4455 0.36 REMARK 500 H2 HOH A 617 H2 HOH A 764 4455 0.48 REMARK 500 O HOH A 617 H1 HOH A 764 4455 0.67 REMARK 500 H2 HOH A 617 O HOH A 764 4455 0.95 REMARK 500 O HOH A 617 H2 HOH A 764 4455 1.04 REMARK 500 H2 HOH A 617 H1 HOH A 764 4455 1.19 REMARK 500 H1 HOH A 617 H1 HOH A 764 4455 1.21 REMARK 500 H1 HOH A 617 O HOH A 764 4455 1.23 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASN A 160 N - CA - CB ANGL. DEV. = 10.9 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 11 -52.81 65.03 REMARK 500 ASN A 77 -22.64 69.41 REMARK 500 PHE A 101 149.55 -170.37 REMARK 500 ASN A 160 162.03 82.04 REMARK 500 ASP A 211 46.20 39.46 REMARK 500 ILE A 223 -166.46 -111.97 REMARK 500 LEU A 242 159.31 -48.21 REMARK 500 ASP A 245 155.63 -45.14 REMARK 500 ASN A 249 43.55 -68.09 REMARK 500 CYS A 256 -8.56 -44.64 REMARK 500 ASN A 257 44.92 -97.41 REMARK 500 LYS A 268 39.71 -81.40 REMARK 500 ASP A 287 80.77 -63.09 REMARK 500 GLN A 289 107.90 69.63 REMARK 500 PRO A 290 31.37 -67.21 REMARK 500 LEU A 297 38.89 -82.38 REMARK 500 ASN A 301 126.51 -170.32 REMARK 500 ASN A 304 74.12 48.01 REMARK 500 SER A 337 64.20 -165.63 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CHIRAL CENTERS REMARK 500 REMARK 500 UNEXPECTED CONFIGURATION OF THE FOLLOWING CHIRAL REMARK 500 CENTER(S) USING IMPROPER CA--C--CB--N CHIRALITY REMARK 500 FOR AMINO ACIDS AND C1'--O4'--N1(N9)--C2' FOR REMARK 500 NUCLEIC ACIDS OR EQUIVALENT ANGLE REMARK 500 M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,6X,F5.1,6X,A1,10X,A1,3X,A16) REMARK 500 REMARK 500 M RES CSSEQI IMPROPER EXPECTED FOUND DETAILS REMARK 500 ASN A 160 23.7 L L OUTSIDE RANGE REMARK 500 SER A 267 23.8 L L OUTSIDE RANGE REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 621 DISTANCE = 5.11 ANGSTROMS REMARK 525 HOH A 623 DISTANCE = 5.04 ANGSTROMS REMARK 525 HOH A 650 DISTANCE = 5.92 ANGSTROMS REMARK 525 HOH A 670 DISTANCE = 5.06 ANGSTROMS REMARK 525 HOH A 671 DISTANCE = 9.08 ANGSTROMS REMARK 525 HOH A 679 DISTANCE = 6.11 ANGSTROMS REMARK 525 HOH A 695 DISTANCE = 6.83 ANGSTROMS REMARK 525 HOH A 721 DISTANCE = 5.37 ANGSTROMS REMARK 525 HOH A 734 DISTANCE = 5.02 ANGSTROMS REMARK 525 HOH A 755 DISTANCE = 5.30 ANGSTROMS REMARK 525 HOH A 764 DISTANCE = 5.48 ANGSTROMS REMARK 525 HOH A 769 DISTANCE = 5.63 ANGSTROMS REMARK 525 HOH A 774 DISTANCE = 6.98 ANGSTROMS REMARK 525 HOH A 901 DISTANCE = 5.81 ANGSTROMS REMARK 525 HOH A 907 DISTANCE = 6.59 ANGSTROMS REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 400 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 57 OD2 REMARK 620 2 HOH A 672 O 110.3 REMARK 620 3 GLU A 324 OE2 96.2 109.4 REMARK 620 N 1 2 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: ACT REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: ASPARTIC PROTEINASES ARE CHARACTERIZED BY TWO REMARK 800 ASP RESIDUES, ONE FROM EACH DOMAIN, CORRESPONDING TO PEPSIN ASP REMARK 800 32, ASP 218. REMARK 800 REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 400 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE A70 A 500 DBREF 1ZAP A 1 342 UNP P28871 CARP2_CANAL 57 398 SEQADV 1ZAP ILE A 45 UNP P28871 VAL 101 CONFLICT SEQADV 1ZAP SER A 81 UNP P28871 LYS 137 CONFLICT SEQADV 1ZAP SER A 164 UNP P28871 ALA 220 CONFLICT SEQADV 1ZAP ASP A 278 UNP P28871 GLU 334 CONFLICT SEQADV 1ZAP THR A 283 UNP P28871 LEU 339 CONFLICT SEQADV 1ZAP LYS A 302 UNP P28871 ASP 358 CONFLICT SEQADV 1ZAP ILE A 327 UNP P28871 LEU 383 CONFLICT SEQADV 1ZAP THR A 338 UNP P28871 ILE 394 CONFLICT SEQRES 1 A 342 GLN ALA VAL PRO VAL THR LEU HIS ASN GLU GLN VAL THR SEQRES 2 A 342 TYR ALA ALA ASP ILE THR VAL GLY SER ASN ASN GLN LYS SEQRES 3 A 342 LEU ASN VAL ILE VAL ASP THR GLY SER SER ASP LEU TRP SEQRES 4 A 342 VAL PRO ASP VAL ASN ILE ASP CYS GLN VAL THR TYR SER SEQRES 5 A 342 ASP GLN THR ALA ASP PHE CYS LYS GLN LYS GLY THR TYR SEQRES 6 A 342 ASP PRO SER GLY SER SER ALA SER GLN ASP LEU ASN THR SEQRES 7 A 342 PRO PHE SER ILE GLY TYR GLY ASP GLY SER SER SER GLN SEQRES 8 A 342 GLY THR LEU TYR LYS ASP THR VAL GLY PHE GLY GLY VAL SEQRES 9 A 342 SER ILE LYS ASN GLN VAL LEU ALA ASP VAL ASP SER THR SEQRES 10 A 342 SER ILE ASP GLN GLY ILE LEU GLY VAL GLY TYR LYS THR SEQRES 11 A 342 ASN GLU ALA GLY GLY SER TYR ASP ASN VAL PRO VAL THR SEQRES 12 A 342 LEU LYS LYS GLN GLY VAL ILE ALA LYS ASN ALA TYR SER SEQRES 13 A 342 LEU TYR LEU ASN SER PRO ASP SER ALA THR GLY GLN ILE SEQRES 14 A 342 ILE PHE GLY GLY VAL ASP ASN ALA LYS TYR SER GLY SER SEQRES 15 A 342 LEU ILE ALA LEU PRO VAL THR SER ASP ARG GLU LEU ARG SEQRES 16 A 342 ILE SER LEU GLY SER VAL GLU VAL SER GLY LYS THR ILE SEQRES 17 A 342 ASN THR ASP ASN VAL ASP VAL LEU LEU ASP SER GLY THR SEQRES 18 A 342 THR ILE THR TYR LEU GLN GLN ASP LEU ALA ASP GLN ILE SEQRES 19 A 342 ILE LYS ALA PHE ASN GLY LYS LEU THR GLN ASP SER ASN SEQRES 20 A 342 GLY ASN SER PHE TYR GLU VAL ASP CYS ASN LEU SER GLY SEQRES 21 A 342 ASP VAL VAL PHE ASN PHE SER LYS ASN ALA LYS ILE SER SEQRES 22 A 342 VAL PRO ALA SER ASP PHE ALA ALA SER THR GLN GLY ASP SEQRES 23 A 342 ASP GLY GLN PRO TYR ASP LYS CYS GLN LEU LEU PHE ASP SEQRES 24 A 342 VAL ASN LYS ALA ASN ILE LEU GLY ASP ASN PHE LEU ARG SEQRES 25 A 342 SER ALA TYR ILE VAL TYR ASP LEU ASP ASP ASN GLU ILE SEQRES 26 A 342 SER ILE ALA GLN VAL LYS TYR THR SER ALA SER SER THR SEQRES 27 A 342 SER ALA LEU THR HET ZN A 400 1 HET A70 A 500 56 HETNAM ZN ZINC ION HETNAM A70 N-ETHYL-N-[(4-METHYLPIPERAZIN-1-YL)CARBONYL]-D- HETNAM 2 A70 PHENYLALANYL-N-[(1S,2S,4R)-4-(BUTYLCARBAMOYL)-1- HETNAM 3 A70 (CYCLOHEXYLMETHYL)-2-HYDROXY-5-METHYLHEXYL]-L- HETNAM 4 A70 NORLEUCINAMIDE HETSYN A70 A70450 FORMUL 2 ZN ZN 2+ FORMUL 3 A70 C42 H70 N6 O5 FORMUL 4 HOH *189(H2 O) HELIX 1 1 PHE A 58 LYS A 60 5 3 HELIX 2 2 PRO A 67 GLY A 69 5 3 HELIX 3 3 LYS A 129 ASN A 131 5 3 HELIX 4 4 VAL A 140 LYS A 146 1 7 HELIX 5 5 ASN A 176 LYS A 178 5 3 HELIX 6 6 GLN A 228 PHE A 238 1 11 HELIX 7 7 ALA A 276 PHE A 279 5 4 HELIX 8 8 ASP A 308 SER A 313 1 6 SHEET 1 A 9 GLY A 122 GLY A 125 0 SHEET 2 A 9 GLN A 25 ASP A 32 1 N ILE A 30 O GLY A 122 SHEET 3 A 9 TYR A 14 VAL A 20 -1 N VAL A 20 O GLN A 25 SHEET 4 A 9 VAL A 3 ASN A 9 -1 N HIS A 8 O ALA A 15 SHEET 5 A 9 THR A 166 PHE A 171 -1 N PHE A 171 O VAL A 3 SHEET 6 A 9 ALA A 154 TYR A 158 -1 N TYR A 158 O GLN A 168 SHEET 7 A 9 ALA A 314 ASP A 319 -1 N TYR A 318 O TYR A 155 SHEET 8 A 9 GLU A 324 GLN A 329 -1 N ALA A 328 O TYR A 315 SHEET 9 A 9 ILE A 184 PRO A 187 -1 N LEU A 186 O ILE A 325 SHEET 1 B 4 TRP A 39 PRO A 41 0 SHEET 2 B 4 GLN A 109 THR A 117 1 N ALA A 112 O VAL A 40 SHEET 3 B 4 SER A 89 ASP A 97 -1 N ASP A 97 O GLN A 109 SHEET 4 B 4 PRO A 79 GLY A 83 -1 N ILE A 82 O SER A 90 SHEET 1 C 2 VAL A 99 PHE A 101 0 SHEET 2 C 2 VAL A 104 ILE A 106 -1 N ILE A 106 O VAL A 99 SHEET 1 D 2 GLY A 173 ASP A 175 0 SHEET 2 D 2 THR A 338 ALA A 340 -1 N SER A 339 O VAL A 174 SHEET 1 E 4 VAL A 213 LEU A 216 0 SHEET 2 E 4 ARG A 195 GLU A 202 -1 N LEU A 198 O VAL A 213 SHEET 3 E 4 ASP A 261 PHE A 266 -1 N ASN A 265 O GLY A 199 SHEET 4 E 4 LYS A 271 PRO A 275 -1 N VAL A 274 O VAL A 262 SHEET 1 F 2 SER A 200 VAL A 203 0 SHEET 2 F 2 LYS A 206 ASN A 209 -1 N ILE A 208 O VAL A 201 SHEET 1 G 2 THR A 224 LEU A 226 0 SHEET 2 G 2 PHE A 298 VAL A 300 1 N ASP A 299 O THR A 224 SHEET 1 H 2 ALA A 280 SER A 282 0 SHEET 2 H 2 CYS A 294 LEU A 296 -1 N GLN A 295 O ALA A 281 SSBOND 1 CYS A 47 CYS A 59 1555 1555 2.03 SSBOND 2 CYS A 256 CYS A 294 1555 1555 2.03 LINK ZN ZN A 400 OD2 ASP A 57 1555 1555 1.80 LINK ZN ZN A 400 O HOH A 672 1555 1555 2.69 LINK ZN ZN A 400 OE2 GLU A 324 1555 1554 1.94 SITE 1 ACT 2 ASP A 32 ASP A 218 SITE 1 AC1 3 ASP A 57 GLU A 324 HOH A 672 SITE 1 AC2 20 VAL A 12 THR A 13 ILE A 30 ASP A 32 SITE 2 AC2 20 GLY A 34 TYR A 84 GLY A 85 ASP A 86 SITE 3 AC2 20 ILE A 119 ILE A 123 ASN A 131 GLU A 193 SITE 4 AC2 20 ASP A 218 GLY A 220 THR A 221 THR A 222 SITE 5 AC2 20 ASN A 301 ILE A 305 HOH A 632 HOH A 902 CRYST1 63.600 98.260 49.280 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015723 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010177 0.000000 0.00000 SCALE3 0.000000 0.000000 0.020292 0.00000